Hybrid View
-
11-10-2012 12:47 AM #1
Titan Member- Ngày tham gia
- Aug 2009
- Bài viết
- 1,008
- Được cám ơn 4 lần trong 3 bài gởi
IMP: Report on the use of capital
Imexpharm Pharmaceutical Joint Stock Company reported the use of the proceeds from its public offering, according to its report dated October 08, 2012:
- Total proceeds from the offering of 3,554,680 shares: VND98,201,510,000
- The amount used until October 08, 2012: VND98,201,510,000 – all of the proceeds, including:
- Paying for Penicillin injection production line: VND45 billion.
- Paying for upgrading equipment for Cao Lanh Factory: VND10 billion.
- Investing in system distribution: VND40,201,501,000.
- Raising the working capital: VND3 billion.
Thông tin của chủ đề
Users Browsing this Thread
Có 1 thành viên đang xem chủ đề này. (0 thành viên và 1 khách vãng lai)
Similar Threads
-
DCL,DMC,IMP,DHG
By caocaomai in forum Doanh nghiệp sàn HoSETrả lời: 32Bài viết cuối: 22-12-2014, 03:17 PM -
IMP: Report on share buyback
By xiuchic in forum STOCKs LISTED IN HoSETrả lời: 0Bài viết cuối: 03-08-2012, 11:16 PM -
IMP: Explanation for the business result in quarter 4/2009
By kieudiemvje in forum STOCKs LISTED IN HoSETrả lời: 0Bài viết cuối: 22-01-2010, 05:41 PM -
IMP: Information disclosure
By phuocpham in forum STOCKs LISTED IN HoSETrả lời: 0Bài viết cuối: 02-01-2010, 12:13 PM
Bookmarks